Traws Pharma, Inc. — Director's Dealing 2015

Jan 21, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-01-12

Reporting Person: Fruchtman Steven M (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.37	2025-01-12	Common Stock (120000)		Direct

Footnotes

F1: These options vest over 4 years in 48 equal monthly installments.